Protein based therapeutic delivery agents: Contemporary developments and challenges.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28458031.
- Also identified by DOI 10.1016/j.biomaterials.2017.04.036 and PMC identifier 5513498.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As unique biopolymers, proteins can be employed for therapeutic delivery. They bear important features such as bioavailability, biocompatibility, and biodegradability with low toxicity serving as a platform for delivery of various small molecule therapeutics, gene therapies, protein biologics and cells. Depending on size and characteristic of the therapeutic, a variety of natural and engineered proteins or peptides have been developed. This, coupled to recent advances in synthetic and chemical biology, has led to the creation of tailor-made protein materials for delivery. This review highlights strategies employing proteins to facilitate the delivery of therapeutic matter, addressing the challenges for small molecule, gene, protein and cell transport.
Medical subject headings
- Biocompatible Materials
- Biopolymers
- Proteins